Chemomab Therapeutics Ltd.
CMMB· Nasdaq
Chemomab Therapeutics Ltd.
- Last sale
- Oct 2, 2026 · +0.38%
- Market cap
- $9.49M
- 7.19M shares
- Filings
- 360
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Cost of Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2,326,000 | reported | |
| FY 2024 | 2024-12-31 | $2,465,000 | reported | |
| FY 2023 | 2023-12-31 | $4,393,000 | reported | |
| FY 2022 | 2022-12-31 | $5,142,000 | reported | |
| FY 2021 | 2021-12-31 | $3,310,000 | reported |
Chemomab Therapeutics Ltd. · CIK 1534248 · Engraved from SEC EDGAR
